Literature DB >> 24529477

Crystal structure of Cas9 in complex with guide RNA and target DNA.

Hiroshi Nishimasu1, F Ann Ran2, Patrick D Hsu2, Silvana Konermann3, Soraya I Shehata3, Naoshi Dohmae4, Ryuichiro Ishitani5, Feng Zhang6, Osamu Nureki7.   

Abstract

The CRISPR-associated endonuclease Cas9 can be targeted to specific genomic loci by single guide RNAs (sgRNAs). Here, we report the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 Å resolution. The structure revealed a bilobed architecture composed of target recognition and nuclease lobes, accommodating the sgRNA:DNA heteroduplex in a positively charged groove at their interface. Whereas the recognition lobe is essential for binding sgRNA and DNA, the nuclease lobe contains the HNH and RuvC nuclease domains, which are properly positioned for cleavage of the complementary and noncomplementary strands of the target DNA, respectively. The nuclease lobe also contains a carboxyl-terminal domain responsible for the interaction with the protospacer adjacent motif (PAM). This high-resolution structure and accompanying functional analyses have revealed the molecular mechanism of RNA-guided DNA targeting by Cas9, thus paving the way for the rational design of new, versatile genome-editing technologies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24529477      PMCID: PMC4139937          DOI: 10.1016/j.cell.2014.02.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  42 in total

1.  Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.

Authors:  Lei S Qi; Matthew H Larson; Luke A Gilbert; Jennifer A Doudna; Jonathan S Weissman; Adam P Arkin; Wendell A Lim
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

2.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

3.  One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

Authors:  Haoyi Wang; Hui Yang; Chikdu S Shivalila; Meelad M Dawlaty; Albert W Cheng; Feng Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2013-05-02       Impact factor: 41.582

4.  CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.

Authors:  Luke A Gilbert; Matthew H Larson; Leonardo Morsut; Zairan Liu; Gloria A Brar; Sandra E Torres; Noam Stern-Ginossar; Onn Brandman; Evan H Whitehead; Jennifer A Doudna; Wendell A Lim; Jonathan S Weissman; Lei S Qi
Journal:  Cell       Date:  2013-07-11       Impact factor: 41.582

5.  High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.

Authors:  Yanfang Fu; Jennifer A Foden; Cyd Khayter; Morgan L Maeder; Deepak Reyon; J Keith Joung; Jeffry D Sander
Journal:  Nat Biotechnol       Date:  2013-06-23       Impact factor: 54.908

6.  Efficient genome editing in zebrafish using a CRISPR-Cas system.

Authors:  Woong Y Hwang; Yanfang Fu; Deepak Reyon; Morgan L Maeder; Shengdar Q Tsai; Jeffry D Sander; Randall T Peterson; J-R Joanna Yeh; J Keith Joung
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

7.  A CRISPR/Cas system mediates bacterial innate immune evasion and virulence.

Authors:  Timothy R Sampson; Sunil D Saroj; Anna C Llewellyn; Yih-Ling Tzeng; David S Weiss
Journal:  Nature       Date:  2013-04-14       Impact factor: 49.962

8.  Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease.

Authors:  Scott J Gratz; Alexander M Cummings; Jennifer N Nguyen; Danielle C Hamm; Laura K Donohue; Melissa M Harrison; Jill Wildonger; Kate M O'Connor-Giles
Journal:  Genetics       Date:  2013-05-24       Impact factor: 4.562

9.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

10.  DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

Authors:  Samuel H Sternberg; Sy Redding; Martin Jinek; Eric C Greene; Jennifer A Doudna
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

View more
  592 in total

1.  Protein engineering of Cas9 for enhanced function.

Authors:  Benjamin L Oakes; Dana C Nadler; David F Savage
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 2.  Determining the specificities of TALENs, Cas9, and other genome-editing enzymes.

Authors:  Vikram Pattanayak; John P Guilinger; David R Liu
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

3.  Decoding non-random mutational signatures at Cas9 targeted sites.

Authors:  Amir Taheri-Ghahfarokhi; Benjamin J M Taylor; Roberto Nitsch; Anders Lundin; Anna-Lina Cavallo; Katja Madeyski-Bengtson; Fredrik Karlsson; Maryam Clausen; Ryan Hicks; Lorenz M Mayr; Mohammad Bohlooly-Y; Marcello Maresca
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

4.  Structure and specificity of the RNA-guided endonuclease Cas9 during DNA interrogation, target binding and cleavage.

Authors:  Eric A Josephs; D Dewran Kocak; Christopher J Fitzgibbon; Joshua McMenemy; Charles A Gersbach; Piotr E Marszalek
Journal:  Nucleic Acids Res       Date:  2015-09-17       Impact factor: 16.971

Review 5.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

6.  A High-Throughput Platform to Identify Small-Molecule Inhibitors of CRISPR-Cas9.

Authors:  Basudeb Maji; Soumyashree A Gangopadhyay; Miseon Lee; Mengchao Shi; Peng Wu; Robert Heler; Beverly Mok; Donghyun Lim; Sachini U Siriwardena; Bishwajit Paul; Vlado Dančík; Amedeo Vetere; Michael F Mesleh; Luciano A Marraffini; David R Liu; Paul A Clemons; Bridget K Wagner; Amit Choudhary
Journal:  Cell       Date:  2019-05-02       Impact factor: 41.582

Review 7.  CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sanjay K Srivastava
Journal:  Semin Cell Dev Biol       Date:  2019-05-04       Impact factor: 7.727

8.  CRISPR-Cas9 Mediated DNA Unwinding Detected Using Site-Directed Spin Labeling.

Authors:  Narin S Tangprasertchai; Rosa Di Felice; Xiaojun Zhang; Ian M Slaymaker; Carolina Vazquez Reyes; Wei Jiang; Remo Rohs; Peter Z Qin
Journal:  ACS Chem Biol       Date:  2017-05-03       Impact factor: 5.100

9.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro E Trevino; Julia Joung; Omar O Abudayyeh; Clea Barcena; Patrick D Hsu; Naomi Habib; Jonathan S Gootenberg; Hiroshi Nishimasu; Osamu Nureki; Feng Zhang
Journal:  Nature       Date:  2014-12-10       Impact factor: 49.962

10.  Exploring the Catalytic Mechanism of Cas9 Using Information Inferred from Endonuclease VII.

Authors:  Hanwool Yoon; Li Na Zhao; Arieh Warshel
Journal:  ACS Catal       Date:  2018-12-28       Impact factor: 13.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.